Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Colin G. Stott
Observed names:
C G Stott,
C. G. Stott,
C. Stott,
C.G. Stott,
Colin G Stott,
Colin Stott,
Stott, Colin
show all 7
Observed institutions:
University of Nottingham,
University of Oxford,
American Epilepsy Society,
GW Pharmaceuticals (United Kingdom)
OpenAlex ID:
A5109062535
Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
2010
·
Luciano De Petrocellis
, Alessia Ligresti
, et al.
·
British Journal of Pharmacology
·
1,000
PDF
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
2011
·
L. De Petrocellis
, P. Orlando
, et al.
·
Acta Physiologica
·
328
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
2016
·
Khalid A. Jadoon
, Stuart H. Ratcliffe
, et al.
·
Diabetes Care
·
276
Validity, reliability, and clinical importance of change in a 0—10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial
2008
·
John T. Farrar
, Andrea B. Troxel
, et al.
·
Clinical Therapeutics
·
264
Non‐THC cannabinoids inhibit prostate carcinoma growthin vitroandin vivo: pro‐apoptotic effects and underlying mechanisms
2012
·
Luciano De Petrocellis
, Alessia Ligresti
, et al.
·
British Journal of Pharmacology
·
222
PDF
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
2010
·
Derick T Wade
, Christine Collin
, et al.
·
Multiple Sclerosis Journal
·
152
A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray
2012
·
C. G. Stott
, L. White
, et al.
·
European Journal of Clinical Pharmacology
·
131
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
2013
·
Colin Stott
, Linda White
, et al.
·
SpringerPlus
·
125
PDF
Differential effectiveness of selected non‐psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment
2016
·
Attila Oláh
, Arnold Markovics
, et al.
·
Experimental Dermatology
·
113
The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
2013
·
E T Wargent
, M S Zaibi
, et al.
·
Nutrition and Diabetes
·
113
PDF
A randomized, double‐blind, placebo‐controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use
2011
·
Kerri Alexandra Schoedel
, Nancy Chen
, et al.
·
Human Psychopharmacology Clinical and Experimental
·
89
A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray
2012
·
C. G. Stott
, L. White
, et al.
·
European Journal of Clinical Pharmacology
·
79
Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent
2019
·
Royston A. Gray
, Colin G. Stott
, et al.
·
Cannabis and Cannabinoid Research
·
65
PDF
A Multiple‐Dose, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray
2013
·
Edward M. Sellers
, Kerri Schoedel
, et al.
·
Clinical Pharmacology in Drug Development
·
57
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis
2012
·
A. Hilliard
, C. Stott
, et al.
·
ISRN Neurology
·
50
PDF
MK-801-induced deficits in social recognition in rats
2015
·
Serena Deiana
, Akihito Watanabe
, et al.
·
Behavioural Pharmacology
·
48
Evaluation of the potential of the phytocannabinoids, cannabidivarin ( CBDV ) and Δ9‐tetrahydrocannabivarin ( THCV ), to produce CB1 receptor inverse agonism symptoms of nausea in rats
2013
·
Erin M Rock
, Martin A Sticht
, et al.
·
British Journal of Pharmacology
·
36
PDF
Cannabinoids for the pharmaceutical industry
2004
·
Colin G. Stott
, Geoffrey W. Guy
·
Euphytica
·
34
The development of Sativex® — a natural cannabis-based medicine
2005
·
Geoffrey W. Guy
, Colin G. Stott
·
Birkhäuser Basel eBooks
·
32
Cannabidiol Does Not Convert to Δ 9 -Tetrahydrocannabinol in an In Vivo Animal Model
2017
·
Louise Wray
, Colin Stott
, et al.
·
Cannabis and Cannabinoid Research
·
23
PDF
The proposed multimodal mechanism of action of cannabidiol (CBD) in epilepsy: modulation of intracellular calcium and adenosine-mediated signaling (P5.5-007)
2019
·
Kathryn Nichol
, Colin Stott
, et al.
·
Neurology
·
14
The Proposed Multimodal Mechanism of Action of Cannabidiol (CBD) in Epilepsy: Modulation of Intracellular Calcium and Adenosine-mediated Signalling
2019
·
Colin G. Stott
, Kathryn Nichol
, et al.
·
Epilepsy & Behavior
·
7
Antiseizure properties of cannabidiol (CBD) are attenuated in the absence of transient receptor potential vanilloid 1 (TRPV1) receptors (S53.004)
2018
·
Benjamin J. Whalley
, Royston A. Gray
, et al.
·
Neurology
·
7
P.6.c.010 Abuse potential of nabiximols oromucosal spray compared with dronabinol and placebo in recreational marijuana users
2010
·
K.A. Schoedel
, N. Chen
, et al.
·
European Neuropsychopharmacology
·
4
Assessment of the Anticonvulsant Effects and Tolerability of GW Pharmaceuticals’ Cannabidiol in the Anticonvulsant Screening Program (P2.038)
2016
·
Nicholas Jones
, Thomas Hill
, et al.
·
Neurology
·
2
Show more works
View as search
Works count:
35
Citation count:
3,272
H-index:
20
I10-index:
21
Year
Topic
Type
